Sponsors (36)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Restores immediate expensing of research and experimental (R&E) expenditures so businesses can deduct those costs in the year paid or incurred instead of amortizing them over time. It also changes the refundable research credit and startup rules—raising and redefining the per-taxpayer refundable credit cap, lengthening the startup election period, and adjusting gross-receipts thresholds—and creates lowered-rate credit options and special averaging rules for certain small businesses. The changes take effect on different dates: the expensing rule applies to tax years beginning after Dec. 31, 2021; the refundable-credit and startup rule changes apply to tax years beginning after Dec. 31, 2024; the small-business credit-rate changes apply to tax years after enactment. The bill alters how businesses compute R&D tax benefits and will affect cash flow, tax liabilities, and IRS administration of R&D incentives.
The bill increases near-term cash flow and simplifies some credit choices for startups and small businesses through immediate expensing and expanded refundable credits, but it reduces federal revenue, creates administrative complexities and irrevocable election trade-offs, and lowers the effective R&D credit for some small firms—trading fiscal cost and compliance burdens for quicker tax relief and simpler options.
Businesses that perform research and experimental (R&E) activities (including startups and manufacturers) can immediately deduct research expenses, reducing taxable income in the year costs are incurred.
Taxpayers can adopt the immediate-expensing method without needing IRS consent in the first year they use it, simplifying initial tax planning and reducing procedural friction.
Firms retain flexibility in how R&D tax benefits interact with deductions and credits because the bill preserves interaction rules and provides elections to adjust credit/deduction treatment, helping some firms choose the more beneficial tax outcome.
Taxpayers and the general public face lower federal revenue because immediate expensing and expanded/refundable credit availability reduce tax receipts, potentially increasing deficits or forcing trade-offs in future taxes or government spending.
Taxpayers who previously capitalized R&E under older amortization rules may face administrative complexity or need to adjust past returns, creating retroactive compliance burdens and potential uncertainty.
Companies that elect amortization options or the reduced-credit elections face administrative burdens and irrevocable choices that can affect future tax outcomes, increasing planning complexity.
Introduced May 7, 2025 by Todd Young · Last progress May 7, 2025